Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannaHALER
- Development stage
- Unknown
- Lead developer
- Kite Pharma
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
CannaHALER is a metered-dose inhaler device designed for the precise pulmonary delivery of medical cannabis, specifically Δ9-tetrahydrocannabinol (THC), to patients. Developed by Kite-Systems in Tel Aviv, the device enables administration of low and accurate doses of THC from plant material, allowing for individualized treatment regimens that meet high pharmaceutical standards. Clinical studies have demonstrated that CannaHALER delivers rapid-onset analgesia with dose-dependent effects and a favorable safety profile in patients with chronic pain conditions such as neuropathic pain and complex regional pain syndrome. The inhaler’s design ensures smokeless consumption, reducing exposure to combustion byproducts and providing an alternative for patients unable to tolerate oral medications[1][2][4].
- Brand names
- cannaHALER
- Other names
- Kite Systems CannaHaler cannabis Inhaler
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on cannaHALER.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannaHALER.